SCHEMBL7957072

SCHEMBL7957072

CN(C)CCOc1c(-c2nc(-c3ccccc3)no2)ccc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.52
SMN1; SMN2 Q16637 7/20 0.52
KDM4E B2RXH2 5/20 0.52
ALDH1A1 P00352 5/20 0.52
MAPK1 P28482 5/20 0.52
TP53 P04637 5/20 0.52
L3MBTL1 Q9Y468 5/20 0.52
HSD17B10 Q99714 4/20 0.52
HPGD P15428 4/20 0.52
TSHR P16473 3/20 0.52
TDP1 Q9NUW8 3/20 0.52
NFKB1 P19838 3/20 0.52
NFKB2 Q00653 3/20 0.52
RELA Q04206 3/20 0.52
ATM Q13315 1/20 0.52
KMT2A Q03164 4/20 0.45
LMNA P02545 3/20 0.45
HTT P42858 2/20 0.45
PTPN1 P18031 2/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958621 0.83 GPR55 (0.48) MAPTSMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL7947777 0.82 TP53 (0.47) MAPTSMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL7947855 0.81 SMN1; SMN2 (0.58) MAPTSMN1; SMN2KDM4EALDH1A1TP53
Irampanel SCHEMBL678128 0.80 HTR7 (0.63) MAPTSMN1; SMN2KDM4EALDH1A1MAPK1
Irampanel SCHEMBL6879876 0.79 HTR7 (0.62) MAPTSMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL7958842 0.77 NPC1 (0.56) MAPTSMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL7961680 0.77 SMN1; SMN2 (0.50) MAPTSMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL7961702 0.76 NPC1 (0.50) MAPTSMN1; SMN2KDM4EALDH1A1MAPK1
SCHEMBL7958685 0.76 NR1H4 (0.62) MAPTSMN1; SMN2KDM4EALDH1A1TP53
SCHEMBL7963733 0.76 HTR7 (0.54) MAPTSMN1; SMN2KDM4EALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277872-B1 ANTIISCHEMIC AGENTS; BRAIN DISORDERS BOEHRINGER INGELHEIM KG (DE) 2001-08-21 US disclosed